| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -36.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INBX returned +314.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +31.2% |
| 1 year | +314.5% |
| All-time high | $129.21 (Apr 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INBX would be worth today ›No. Inhibrx Biosciences, Inc. has not paid a dividend in the past 12 months.
Inhibrx Biosciences, Inc. stock trades on NASDAQ under the ticker symbol INBX.
Inhibrx Biosciences, Inc. is part of the Healthcare sector.
Inhibrx Biosciences, Inc. has a market cap of 1.53B USD, based on the latest quote.
Inhibrx Biosciences, Inc. is expected to report earnings around Nov 13, 2026. That date is an estimate and has not been confirmed by the company.
